Articles from Biotech Business (September 1, 1999)

1-7 out of 7 article(s)

Title	Author	Type	Words
COULTER/SMITHKLINE GET FDA PRIORITY REVIEW STATUS FOR BEXXAR.			564
FDA APPROVES ANTAGON FOR PREMATURE LEUTENIZING HORMONE SURGES.			653
FDA APPROVES TOPAMAX FOR PEDIATRIC PATIENTS WITH EPILEPSY.			581
HALSEY DRUG GETS ANDA APPROVAL.			173
PNEUMOCOCCAL CONJUGATE VACCINE GETS FDA PRIORITY REVIEW STATUS.			185
TITAN PARKINSON'S DISEASE CELL THERAPY EFFICACIOUS.			527
UNIMED'S ANDROGEL NDA FILED WITH FDA FOR 12-MONTH REVIEW.			153